Gastrointestinal (GI) cancers target the digestive tract, such as the esophagus, stomach, liver, pancreas, colon, and rectum. The session "Gastrointestinal Cancer" emphasizes knowledge regarding these cancers, risk factors associated with them, and current progress in diagnosis and treatment.".
GI cancers tend to be symptomatically mild and thus early diagnosis is crucial for optimizing the prognosis of such patients. This session identifies contemporary diagnostic methods like endoscopy, imaging, and molecular diagnostics that enable identification of tumors at more advanced stages. Treatment protocols usually consist of a combination of surgery, chemotherapy, radiation, and targeted therapies, all of which are individually customized depending on the patient's cancer type and stage.
New findings in gastrointestinal cancer are driving personalized medicine strategies. Genetic testing and biomarker identification allow clinicians to choose treatments that are most suitable for a given individual, minimizing side effects and maximizing survival. The session also covers the roles of lifestyle, diet, and supportive care in multidisciplinary cancer treatment.
Participants will be enlightened by the latest treatment regimens, cutting-edge research, and multidisciplinary care strategies for gastrointestinal malignancies. This session highlights the importance of early detection, tailored treatment plans, and collaborative care in improving outcomes and quality of life for GI cancer patients.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
